Clinical trials are typically conducted over a population within a defined time period in order to illuminate certain characteristics of a health issue or disease process. These cross-sectional studies provide a snapshot of these disease processes over a large number of people but do not allow us to model the temporal nature of disease, which is essential for modelling detailed prognostic predictions. Longitudinal studies on the other hand, are used to explore how these processes develop over time in a number of people but can be expensive and time-consuming, and many studies only cover a relatively small window within the disease process. This paper explores the application of intelligent data analysis techniques for building reliable models of disease progression from both cross-sectional and longitudinal studies. The aim is to learn disease 'trajectories' from cross-sectional data by building realistic trajectories from healthy patients to those with advanced disease. We focus on exploring whether we can 'calibrate' models learnt from these trajectories with real longitudinal data using Baum-Welch re-estimation.
Introduction
Degenerative diseases such as cancer, Parkinson's disease, and glaucoma are characterised by a continuing deterioration to organs or tissues over time. This monotonic increase in severity of symptoms is not always straightforward however. The rate can vary in a single patient during the course of their disease so that sometimes rapid deterioration is observed and other times the symptoms of the sufferer may stabilise (or even improve -for example when medication is used). Interventions such as medication or surgery can make a huge difference to quality of life and slow the process of disease progression but they rarely change the long term prognosis. The characteristics of many degenerative diseases is therefore a general transition from healthy to early onset to advanced stages. Longitudinal studies [1] measure clinical variables from a number of people over time. Often, the results of multiple tests are recorded, generating Multivariate Time-Series (MTS) data. This is common for patients who have high risk indicators of disease where they are monitored regularly prior to diagnosis. For example, patients with high intra-ocular pressure are brought in to clinic for visual field tests every six months as they are at high risk of developing glaucoma. The advantages of longitudinal data is that the temporal details of the disease progression can be determined. However, the data is often limited in terms of the cohort size, due to the expensive nature of the studies. Cross-sectional studies record attributes (such as clinical test results and demographics) across a sample of the population, thus providing a snapshot of a particular process but without any measurement of progression of the process over time [2] . An advantage of cross sectional studies is that they capture the diversity of a sample of the population and therefore the degree of variation in the symptoms. The main disadvantage of such studies is that the progression of disease are inherently temporal in nature and the time dimension is not captured. For longitudinal analysis, the patients are usually already identified as being at risk and therefore, controls are usually not available and the early stages of the disease may have been missed as is explored in [3] . Previously, a resampling approach known as the Temporal BootStrap (TBS) [6] has been developed that aims to build multiple trajectories through cross sectional data in order to approximate genuine longitudinal data. These 'Pseudo Time-Series' (PTS) can then be used to build approximate temporal models for prediction. This approach has been extended in order to cluster important stages in disease progression using Hidden Markov Models (HMMs) [7] . However, the use of cross-sectional data alone will mean that no genuine timestamps have been used to infer the models and so they only capture an ordering without real temporal information.
In this paper, we explore how to minimise the expensive process of longitudinal data collection by taking models that are learnt from cross-sectional studies using pseudo temporal methods and updating with limited longitudinal data. We do this by using the Baum-Welch algorithm to update stochastic models learnt from pseudo time-series. Essentially, we are integrating cross-sectional and longitudinal data to increase the temporal information and the diversity of data from a large population. Many data integration techniques address representation heterogeneity where similar data is stored in different forms, as is common in bioinformatics data [8].
Methods

Generating Pseudo Time-Series
Let a dataset D be defined as a real valued matrix where m (rows) is the number of samples -here patients -and n (columns) is the number of variables -clinical test data. We define D(i) as the ith row of matrix D. The vector C = [c 1 , c 2 , . . . , cm] represents defined classes, where each c i ∈ {0, 1} corresponds to the sample i, c i = 0 represents that sample i is a healthy case, and c i = 1 represents that sample i is a diseased case. These classifications are based upon the diagnoses made by experts. We define a time-series as a real valued T (row) by n (column) matrix where each row corresponds to an observation measured over T time points. We say that if T (i) was observed before T (j) then
